7RWL の概要
| エントリーDOI | 10.2210/pdb7rwl/pdb |
| EMDBエントリー | 24718 24719 |
| 分子名称 | Capsid protein VP1 (1 entity in total) |
| 機能のキーワード | exo-aav, exosome-associated adeno-associated virus, ea-aav, envelope-associated adeno-associated virus, virus |
| 由来する生物種 | Adeno-associated dependoparvovirus A |
| タンパク質・核酸の鎖数 | 60 |
| 化学式量合計 | 4921881.12 |
| 構造登録者 | Hull, J.A.,Mietzsch, M.,Chipman, P.,Strugatsky, D.,McKenna, R. (登録日: 2021-08-20, 公開日: 2021-10-20, 最終更新日: 2025-05-14) |
| 主引用文献 | Hull, J.A.,Mietzsch, M.,Chipman, P.,Strugatsky, D.,McKenna, R. Structural characterization of an envelope-associated adeno-associated virus type 2 capsid. Virology, 565:22-28, 2021 Cited by PubMed Abstract: Adeno-associated virus (AAV) are classified as non-enveloped ssDNA viruses. However, AAV capsids embedded within exosomes have been observed, and it has been suggested that the AAV membrane associated accessory protein (MAAP) may play a role in envelope-associated AAV (EA-AAV) capsid formation. Here, we observed and selected sufficient homogeneous EA-AAV capsids of AAV2, produced using the Sf9 baculoviral expression system, to determine the cryo-electron microscopy (cryo-EM) structure at 3.14 Å resolution. The reconstructed map confirmed that the EA-AAV capsid, showed no significant structural variation compared to the non-envelope capsid. In addition, the Sf9 expression system used implies the notion that MAAP may enhance exosome AAV encapsulation. Furthermore, we speculate that these EA-AAV capsids may have therapeutic benefits over the currently used non-envelope AAV capsids, with advantages in immune evasion and/or improved infectivity. PubMed: 34638006DOI: 10.1016/j.virol.2021.09.010 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (3.14 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






